Revvity (RVTY) Cash from Operations (2009 - 2026)
Revvity's (RVTY) quarterly Cash from Operations came in at $191.9 million in Q3 2026, up 42.9% on a YoY basis from $134.3 million in Q3 2025, and up 52.47% quarter-over-quarter from $125.9 million in Q2 2026.
Analysis
Revvity (RVTY) Cash from Operations (2009 - 2026) Analysis & Trends
Revvity (RVTY) has reported Cash from Operations for 18 consecutive years, with $191.9 million the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, Cash from Operations rose 42.9% year-over-year to $191.9 million; the trailing twelve-month figure through Jul 2026 stood at $638.4 million (up 6.24% YoY), and the FY2025 full-year result was $589.0 million, down 11.43% from the prior year.
- Cash from Operations grew to $191.9 million in Q3 2026 per RVTY's latest filing, from $125.9 million in the prior quarter.
- Across five years, Cash from Operations topped out at $384.7 million in Q4 2023 and bottomed at -$395.3 million in Q1 2023.
- Historically, Cash from Operations has averaged $111.4 million across 5 years, with a median of $144.4 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Cash from Operations plunged 78.02% in 2023, then surged 568.91% in 2024.
- Over 5 years, Cash from Operations stood at $326.1 million in 2022, then increased by 17.97% to $384.7 million in 2023, then tumbled by 54.39% to $175.5 million in 2024, then advanced by 3.7% to $182.0 million in 2025, then gained by 5.49% to $191.9 million in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered $191.9 million, $125.9 million, and $182.0 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 2.13 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 1.53 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 519.00 Mn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 201.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 191.94 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 95.42 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 98.70 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 32.77 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 16.97 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -77.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | 191.94 Mn |
| Apr 5, 2026 | 125.89 Mn |
| Dec 28, 2025 | 181.96 Mn |
| Sep 28, 2025 | 138.58 Mn |
| Jun 29, 2025 | 134.32 Mn |
| Mar 30, 2025 | 134.10 Mn |
| Dec 29, 2024 | 175.47 Mn |
| Sep 29, 2024 | 157.01 Mn |
| Jun 30, 2024 | 182.33 Mn |
| Mar 31, 2024 | 150.15 Mn |
| Dec 31, 2023 | 384.73 Mn |
| Oct 1, 2023 | -33.49 Mn |
| Jul 2, 2023 | -143.53 Mn |
| Apr 2, 2023 | 71.67 Mn |
| Jan 1, 2023 | -395.35 Mn |
| Apr 3, 2022 | 326.12 Mn |
| Oct 3, 2021 | 313.80 Mn |
| Jul 4, 2021 | 287.86 Mn |
| Apr 4, 2021 | 473.50 Mn |
| Jan 3, 2021 | 482.10 Mn |